A. Oveta Fuller, Ph.D.

Professional portrait of a middle aged Black woman with short curly hair wearing a black blazer

Almyra Oveta Fuller, Ph.D., associate professor of microbiology and immunology, died November 18, 2022, at age 67.

Fuller earned a Ph.D. from the Uni­versity of North Carolina at Chapel Hill in 1983 and joined the Michigan Medi­cine faculty in 1988. Fuller was science advisor at the African Methodist Episcopal Church - Service and Development Agency for HIV and AIDS Prevention. Fuller was the associate director (2014- 16) and interim director (2016-17) of the African Studies Center at the U-M International Institute. She received many awards for her community engage­ment, including the Detroit-Windsor Metropolitan Council of Churches’ 2017 “Trumpet Award” for Excellent Service in Community Engagement and the 2022 Sarah Goddard Power Award from the U-M Academic Women’s Caucus.

Fuller was a distinguished virologist who focused her work on herpesvirus entry and pathogenesis and translational research for HIV/AIDS elimination. She was dedicated to global health and health equity interventions. For almost two decades, she worked with church leaders in Botswana, South Africa, and Zambia to develop and test a prevention model that engages clergy and faith leaders to address HIV/AIDS.

She was the first woman to receive tenure in the Department of Microbiology and Immunology, and she never stopped advocating for opportunities for women and trainees, especially from diverse backgrounds. She touched many lives through her classes, fieldwork, ministry, and service.

This obituary is based on one published by the Department of Microbiology and Immunology.

Featured News & Stories

Doctor performing a test
News Release

Michigan Alzheimer's Disease Research Center receives $22M to advance efforts statewide

NIH renews $22M for Michigan Alzheimer's Disease Research Center, supporting a first-of-its-kind statewide partnership and dementia research.
red blood cells going through clear tube red background
Health Lab

FDA-approved drug offers hope for patients with polycythemia vera, a rare bone marrow disorder

FDA-approved rusfertide offers new hope for polycythemia vera patients by reducing phlebotomy dependence, easing symptoms, and improving daily life.
little girl with yellow shirt on soccer field smiling ready for soccer
Health Lab

Pediatric patient treated for rare kidney cancer

When 18-month-old Maria was diagnosed with an exceptionally rare kidney cancer, specialists at C.S. Mott Children's Hospital created a customized treatment plan that saved her life.
bats flying in air purple sky pink
Health Lab

Rabies is on the rise: Experts offer advice

With rabies on the rise, infectious disease experts from Michigan Medicine share advice.
Well-Being at Michigan Medicine with Dr. Elizabeth Harry
Well-Being at Michigan Medicine

AI, Well-Being and the Human Connection

Artificial intelligence is changing healthcare — but what does that mean for the people who deliver and receive care? Cornelius James, M.D., FACP, FNAP, a clinical assistant professor and primary care physician at for U-M Departments of Internal Medicine and Pediatrics, joins Chief Well-Being Officer Elizabeth Harry, M.D., to explore AI literacy, clinical judgment, governance, education and well-being. They discuss how healthcare can embrace new technologies while protecting human connection, empathy, wisdom and the meaningful moments that define care.
pink graphic of uterus close up and egg dropping through
Health Lab

PCOS has a new name

Globally, 1 in 8 women live with polyendocrine metabolic ovarian syndrome, formerly known as PCOS. The name change recognizes the many challenges for women trying to conceive.